Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chahine

Showing results (41-50 of 243) with videos related to

Pageof 25
Sort By:
Parkinsonism & Related Disorders|January 11, 2011
Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measuresL M Chahine, A Ahmed, Z Sun
Harvard Review of Psychiatry|April 27, 2010
The elderly safety imperative and antipsychotic usageLama M Chahine, Diler Acar, Zeina Chemali
European Journal of Neurology|December 4, 2008
Palliative care needs of patients with neurologic or neurosurgical conditionsL M Chahine, B Malik, M Davis
Harvard Review of Psychiatry|July 29, 2009
The use of selective serotonin reuptake inhibitors in elderly patientsZeina Chemali, Lama M Chahine, Gregory Fricchione
Journal of Pain and Symptom Management|July 22, 2008
Complex regional pain syndrome after infliximab infusionLama M Chahine, Robert Patrick, Jinny Tavee
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 6, 2001
Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channelsK Vijayaragavan, M E O'Leary, M Chahine
The Journal of Membrane Biology|July 1, 1996
Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunits expressed in tsA201 cellsM Chahine, E Plante, R G Kallen
Molecular Pharmacology|December 4, 2003
Closing and inactivation potentiate the cocaethylene inhibition of cardiac sodium channels by distinct mechanismsM E O'Leary, M Digregorio, M Chahine
Neurology|May 17, 2023
Physical Activity and the Risk of Parkinson Disease: Moving in the Right DirectionLana M Chahine, Sirwan K L Darweesh
Frontiers in Pharmacology|October 10, 2022
Editorial: Emerging perspectives in sodium channelopathiesJ R Groome, H J Ray, M Chahine
Pageof 25

Showing results (41-50 of 243) with videos related to

Sort By:
Pageof 25
Parkinsonism & Related Disorders|January 11, 2011
Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measuresL M Chahine, A Ahmed, Z Sun
Harvard Review of Psychiatry|April 27, 2010
The elderly safety imperative and antipsychotic usageLama M Chahine, Diler Acar, Zeina Chemali
European Journal of Neurology|December 4, 2008
Palliative care needs of patients with neurologic or neurosurgical conditionsL M Chahine, B Malik, M Davis
Harvard Review of Psychiatry|July 29, 2009
The use of selective serotonin reuptake inhibitors in elderly patientsZeina Chemali, Lama M Chahine, Gregory Fricchione
Journal of Pain and Symptom Management|July 22, 2008
Complex regional pain syndrome after infliximab infusionLama M Chahine, Robert Patrick, Jinny Tavee
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 6, 2001
Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channelsK Vijayaragavan, M E O'Leary, M Chahine
The Journal of Membrane Biology|July 1, 1996
Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunits expressed in tsA201 cellsM Chahine, E Plante, R G Kallen
Molecular Pharmacology|December 4, 2003
Closing and inactivation potentiate the cocaethylene inhibition of cardiac sodium channels by distinct mechanismsM E O'Leary, M Digregorio, M Chahine
Neurology|May 17, 2023
Physical Activity and the Risk of Parkinson Disease: Moving in the Right DirectionLana M Chahine, Sirwan K L Darweesh
Frontiers in Pharmacology|October 10, 2022
Editorial: Emerging perspectives in sodium channelopathiesJ R Groome, H J Ray, M Chahine
Pageof 25